A Phase IV Study in Drug-Naive Patients With T2DM in China

NCT03344341 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
304
Enrollment
INDUSTRY
Sponsor class

Stopped Study overall progress behind of scheduled timeline. Study was terminated early due to company decision.

Conditions

Interventions

Sponsor

AstraZeneca